SCHEMBL873777

SCHEMBL873777

Cc1cccc(OCC(=O)N2CCC[C@H]2C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)[C@@H]4CCCN4C(=O)COc4cccc(Cl)c4)cc3)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 2/20 0.49
CREBBP Q92793 2/20 0.49
ALDH1A1 P00352 4/20 0.48
GAA P10253 2/20 0.47
CPT2 P23786 1/20 0.46
CPT1A P50416 1/20 0.46
TSHR P16473 2/20 0.45
PABPC1 P11940 1/20 0.45
NPSR1 Q6W5P4 4/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
F2 P00734 1/20 0.44
RAB9A P51151 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844903 0.95 EP300 (0.51) EP300CREBBPALDH1A1CPT2CPT1A
SCHEMBL10120083 0.87 CPT2 (0.46) EP300CREBBPALDH1A1CPT2CPT1A
SCHEMBL844882 0.84 PABPC1 (0.59) EP300CREBBPALDH1A1GAACPT2
SCHEMBL845373 0.80 ALDH1A1 (0.57) ALDH1A1GAATSHRNPSR1POLB
SCHEMBL845382 0.80 EP300 (0.52) EP300CREBBPALDH1A1GAATSHR
SCHEMBL845342 0.78 ALDH1A1 (0.59) ALDH1A1GAATSHRNPSR1POLB
SCHEMBL845206 0.77 CYP2C9 (0.52) EP300CREBBPALDH1A1GAATSHR
SCHEMBL844898 0.75 ALDH1A1 (0.54) EP300CREBBPALDH1A1TSHRNPSR1
SCHEMBL10119342 0.75 ALDH1A1 (0.45) EP300CREBBPALDH1A1GAATSHR
SCHEMBL845251 0.74 PABPC1 (0.50) EP300CREBBPALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed